Category

China

Daily Brief China: China Traditional Chinese Medicine, Alibaba Group Holding , Midea Group Co Ltd A, KE Holdings , Jiangsu Zenergy Battery Technologies and more

By | China, Daily Briefs

In today’s briefing:

  • China Traditional Chinese Medicine (570 HK): Relief as Update Favours the Bulls
  • TCM (570 HK): A Spoonful Of Sugar …
  • Alibaba (9988 HK/BABA): 1Q25, Growth Lower Than Expectation, But Many Expansion Plans Following
  • Midea Group (000333 CH): Index Implications at US$3bn Issue Size
  • [KE Holdings Inc. (BEKE US, BUY, TP US$24) TP Change]: Market Share Gain Is the Main Catalyst
  • Jiangsu Zenergy Battery Technologies Pre-IPO Tearsheet


China Traditional Chinese Medicine (570 HK): Relief as Update Favours the Bulls

By Arun George

  • China Traditional Chinese Medicine (570 HK)’s monthly update reinforces the bull case. The gross spread has remained uncomfortably high since falling on no news on 26 June. 
  • The monthly update will relieve the bulls, as the consortium has finally made the regulatory submissions. The update stresses that the filing delay is due to an unwieldy consortium. 
  • Potential stumbling blocks remain, which should not be an issue. Nevertheless, the risk (17.7% downside to the undisturbed price)/reward (21.4% gross spread) remains attractive. 

TCM (570 HK): A Spoonful Of Sugar …

By David Blennerhassett

  • A 14.8% gain month-to-date, including this past Monday’s 6.5% pop – you just knew something positive was taking place behind closed doors. And leaking its way into the public.   
  • So it was no real surprise to read in the latest monthly update announcement on the HKEx that various regulatory approvals are almost, but not quite, satisfied.
  • The wording in the announcement strikes a positive tone. Even remaining conservative on the timeline, this could be wrapped up before year-end. 

Alibaba (9988 HK/BABA): 1Q25, Growth Lower Than Expectation, But Many Expansion Plans Following

By Ming Lu

  • Alibaba’s revenue grew by 4% YoY in 1Q25 due to the stagnancy in e-commerce.
  • However, many expansion plans follow, including overseas market, physical stores, and fresh food wholesale.
  • We set an upside of 51% and a price target of HK$115 for March 2025.

Midea Group (000333 CH): Index Implications at US$3bn Issue Size

By Brian Freitas

  • Midea Group Co Ltd A (000333 CH) has got approval to list on the HKEX (388 HK) and reports are that the listing could be up to US$3bn.
  • That issue size is around half of the maximum that the company can issue. But it would still need cornerstone investors and a nice discount on the H-shares.
  • The stock will still get included in some indices even with the scaled down size, and inclusion in Southbound Stock Connect is a given.

[KE Holdings Inc. (BEKE US, BUY, TP US$24) TP Change]: Market Share Gain Is the Main Catalyst

By Eric Wen

  • KE Holdings (BEKE) reported C2Q24 revenue 12%/9% higher than our estimates/consensus, and non-GAAP NI 19%/49% higher than our estimates/consensus, due to market share gain and take rate hike.
  • We particularly like its business scalability, as its agent efficiency kept stable despite growing connected agents.
  • We maintain the stock as BUY rating and raise TP to US$24 to reflect the better growth outlook from market share gains.

Jiangsu Zenergy Battery Technologies Pre-IPO Tearsheet

By Ethan Aw

  • Jiangsu Zenergy Battery Technologies (JSZENERGY CH) is looking to raise up to US$300m in its upcoming HK IPO. The deal will be run by CICC, and CMB International.
  • Jiangsu Zenergy Battery Technologies (Zenergy from hereon) is an EV and energy storage system (ESS) battery manufacturer in China. 
  • It provides integrated battery solutions, encompassing battery cells, modules, packs, racks, and battery management systems dedicated to large-scale applications of electrochemical products to interconnect omni-scenarios of land, sea and air.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Tencent, Midea Group Co Ltd A, Fu Shou Yuan, TAL Education and more

By | China, Daily Briefs

In today’s briefing:

  • Tencent (700 HK): 2Q24, Gross Margins of All Business Lines Improved Significantly
  • Tencent 2Q: Recent Launch of DnF Mobile Helps Domestic Gaming Return to Growth
  • Midea A/H Listing – Getting Closer to the US$3bn+ Raising, Has a Narrow Window
  • Fu Shou Yuan (1448.HK) – Negative Growth in 24H1 Seems Inevitable
  • TAL Education Group: A Tale Of Expansion and Diversification in Learning Devices! – Major Drivers


Tencent (700 HK): 2Q24, Gross Margins of All Business Lines Improved Significantly

By Ming Lu

  • Total revenue increased by 8% YoY in 2Q24, lightly higher than 1Q24 and 4Q23.
  • The gross margins of all business lines Improved significantly YoY.
  • We set the upside at 35% and the price target at HK$506 for the end of 2025. Buy.

Tencent 2Q: Recent Launch of DnF Mobile Helps Domestic Gaming Return to Growth

By Shifara Samsudeen, ACMA, CGMA

  • Tencent (700 HK) reported 2Q2024 results today which beat consensus. Domestic gaming resumed growth driven by the successful launch of DnF Mobile which continues to dominate charts in China.
  • All three business segments saw improvement in margins driven by Tencent’s high-margin businesses incl. mini-programs, video accounts, short-videos, etc.
  • We expect continued recovery in Tencent’s earnings, however, remain cautious given slowdown in consumption spending and macroeconomic uncertainties.

Midea A/H Listing – Getting Closer to the US$3bn+ Raising, Has a Narrow Window

By Sumeet Singh

  • Midea Group Co Ltd A (000333 CH) one of the world’s largest home appliance producers, aims to raise up to US$3bn in its H-share listing.
  • Midea Group is one of the world’s largest home appliance manufacturing companies with a presence in over 200 countries. Its A-shares have been listed since 2013.
  • We have covered the company and deal background in our previous notes. In this note, we talk about the updates since then.

Fu Shou Yuan (1448.HK) – Negative Growth in 24H1 Seems Inevitable

By Xinyao (Criss) Wang

  • According to the management, the performance of 24H1 should be better than that of 21H1, but Fu Shou Yuan’s performance in 2024 full year may still fall short of expectations.
  • In the future, the development strategy of Fu Shou Yuan would rely more on endogenous growth. Without aggressive M&A, long-term revenue growth rate could fall to single digit.
  • Special dividends will continue in the future. However, one major risk for Fu Shou Yuan is policy risk. The bottom line is the demand for the funeral industry always exists.

TAL Education Group: A Tale Of Expansion and Diversification in Learning Devices! – Major Drivers

By Baptista Research

  • TAL Education Group delivered a robust set of results in its fiscal first quarter of 2025, showcasing significant revenue growth and strategic expansions in both its learning services and content solutions sectors.
  • These outcomes reflect the company’s focused execution on its operational strategies and its adaptability to the evolving educational needs.
  • Financially, TAL Education Group reported a net revenue of USD 414.2 million, a substantial increase of 50.4% from the previous year, paralleled by a 56.9% increase in RMB terms.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: ASM Pacific Technology, CPMC Holdings, Greatview Aseptic Packaging, Tencent, PICC Property & Casualty H, WeRide, Pop Mart International Group L, Yuexiu Property and more

By | China, Daily Briefs

In today’s briefing:

  • HSCEI/HSTECH/HSIII Index Rebalance Preview: Potential Changes, Flow & Positioning
  • CPMC Holdings (906 HK): A Carefully Caveated Board Recommendation of Changping Industrial’s Offer
  • Greatview Aseptic Packaging (468.HK) – The Story Behind The “Hostile Offer”
  • Quiddity Leaderboard HSTECH Sep 24: Expected ADD and DEL Have 10+ Days to Trade
  • Tencent to Report 2Q FY24 Results (What Is Priced?), MSC Index Changes for Aug Rebalance Published
  • Quiddity Leaderboard HSCEI Sep 24: Announcement Soon; Updated Flow Expectations and Trade Idea
  • WeRide IPO – Stiff Competition and Bleak Sentiment.  Premium Valuation Doesn’t Help
  • WeRide IPO: High-Risk Venture Investment and Unproven Business Model
  • BUY/SELL/HOLD: Hong Kong Stock Updates (August 12)
  • Morning Views Asia: Guangzhou R&F Properties, JSW Steel Ltd, Yuexiu Property


HSCEI/HSTECH/HSIII Index Rebalance Preview: Potential Changes, Flow & Positioning

By Brian Freitas


CPMC Holdings (906 HK): A Carefully Caveated Board Recommendation of Changping Industrial’s Offer

By Arun George

  • The CPMC Holdings (906 HK) Board recommends that shareholders accept Changping Industrial’s HK$6.87 offer, which the IFA opines is fair and reasonable.
  • The Board’s carefully crafted and suitably caveated recommendation acknowledges that shares continue to trade through terms and ORG Technology Co., Ltd. A (002701 CH)’s HK$7.21 offer is higher but preconditional. 
  • Based on ORG’s shareholding/irrevocable and volume traded above terms, Changping Industrial’s offer has little chance of success. It remains a question of when, not if, Changping Industrial will bump.

Greatview Aseptic Packaging (468.HK) – The Story Behind The “Hostile Offer”

By Xinyao (Criss) Wang

  • The connection between Newjf and Greatview is deep. Newjf expressed an interest in acquiring Greatview early on, but the two parties didn’t reach an agreement. Greatview is not entirely “innocent”.
  • Newjf’s decision to forcibly acquire Greatview at this moment should be made after careful consideration. Mengniu may not necessarily oppose this merger. Mengniu is likely to take a neutral stance. 
  • Newjf’s Offer is attractive. In the absence of a more realistic action by Greatview to make a higher Offer, we advise investors not to walk away from Newjf’s Offer easily.

Quiddity Leaderboard HSTECH Sep 24: Expected ADD and DEL Have 10+ Days to Trade

By Janaghan Jeyakumar, CFA

  • The HSTECH Index tracks the performance of the top 30 technology companies listed in Hong Kong that have high business exposure to certain technology themes.
  • There could be one index change during the September 2024 index rebal event. The official results will be announced after market close on 16th August 2024.
  • In this insight, we take a look at our latest flow expectations based on closing prices on Monday 12th August 2024.

Tencent to Report 2Q FY24 Results (What Is Priced?), MSC Index Changes for Aug Rebalance Published

By Charlotte van Tiddens, CFA

  • Last night, MSC published index changes due at the August rebalance. There will be no changes to SA constituents.
  • The rebalance is set to take place at the end of the month on Friday the 30th.
  • Tomorrow after the HK close, Tencent is expected to report results for 2Q FY24.

Quiddity Leaderboard HSCEI Sep 24: Announcement Soon; Updated Flow Expectations and Trade Idea

By Janaghan Jeyakumar, CFA

  • The HSCEI serves as a benchmark to reflect the overall performance of the top 50 “Mainland China” securities listed in Hong Kong.
  • The index changes and indicative weights for the September 2024 index rebal event is expected to be announced after market close on Friday 16th August 2024.
  • In this insight, we take a look at our latest expectations for capping flows based on current prices.

WeRide IPO – Stiff Competition and Bleak Sentiment.  Premium Valuation Doesn’t Help

By Clarence Chu

  • WeRide (WRD US) is looking to raise US$119m in its US IPO.
  • WeRide provides autonomous driving products and services from L2 to L4 of driving automation.
  • We had looked at the firm’s past performance in our earlier notes. In this note, we discuss our thoughts on valuation.

WeRide IPO: High-Risk Venture Investment and Unproven Business Model

By Andrei Zakharov

  • WeRide, a pure-play autonomous driving company with operations in 7 countries, may raise up to $120M in upcoming IPO in the United States.
  • WeRide is expected to IPO this week. The company’s amended prospectus puts the price range per ADS at $15.50 to $18.50, implying a market cap of ~$4.6B at the midpoint.
  • The company has raised ~$1.4B in equity financing to date and was backed by Qiming Venture Partners and the venture capital fund of the Renault Nissan Mitsubishi Alliance, among others.

BUY/SELL/HOLD: Hong Kong Stock Updates (August 12)

By David Mudd


Morning Views Asia: Guangzhou R&F Properties, JSW Steel Ltd, Yuexiu Property

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Tencent, Yum China Holdings , Giant Biogene, CPMC Holdings, Guangzhou Automobile Group, WeRide, Alibaba Group Holding , BYD and more

By | China, Daily Briefs

In today’s briefing:

  • Tencent (700 HK): 2Q24 Preview, Both Growth and Margin to Improve
  • The Heat Is On: News Flow and Sentiment in CHINA / HONG KONG (August 10)
  • Hang Seng Index (HSI) Rebalance Preview: Inclusion Candidates for September
  • HK Connect SOUTHBOUND Flows (To 9 Aug 2024); Tencent the Big Buy Again
  • CPMC (906 HK) Responds To Champion’s Offer
  • A/H Premium Tracker (To 9 Aug 2024): Global Market Vol. SB Bought. NB Sold. Premia Down.
  • WeRide (WRD US) IPO: The Bear Case
  • Alibaba (BABA US): 1Q25 Preview, Stable Growth and Margin, But Overly Impacted
  • China Consumption Weekly (12 Aug 2024): Geely, Li Auto, JD.com, Alibaba, Tencent, DDL
  • Mainland Connect NORTHBOUND Flows (To 9 Aug 2024): Back to Net Selling of Renewables and Consumer


Tencent (700 HK): 2Q24 Preview, Both Growth and Margin to Improve

By Ming Lu

  • We believe total revenue will grow by 9% YoY and game revenue began to rise in 2Q24.
  • We believe the operating margin will continue to improve YoY in 2Q24 after the seven-year high in 1Q24.
  • We set the upside at 35% and the price target at HK$496 for the end of 2025.

The Heat Is On: News Flow and Sentiment in CHINA / HONG KONG (August 10)

By David Mudd


Hang Seng Index (HSI) Rebalance Preview: Inclusion Candidates for September

By Brian Freitas

  • Post market close on Friday, Hang Seng Indexes will announce the changes for the Hang Seng Index (HSI INDEX) that will be implemented at the close on 6 September.
  • With no constituent changes in March and 1 add/1 delete in June, there could be more changes in September with Health Care stocks among the potential inclusions.
  • Changes to the Hang Seng Industry Classification System (HSICS) will be implemented from the September rebalance and that will alter industry coverage.

HK Connect SOUTHBOUND Flows (To 9 Aug 2024); Tencent the Big Buy Again

By Travis Lundy

  • SOUTHBOUND was again a net buyer, for HK$15.2bn this week (now 27wks in a row of net buying), on smallish two-way volumes. Better than the previous month but still low.
  • Bank net buying, which had spiked the previous week, didn’t follow through.
  • There were three ETFs in the top 15 SOUTHBOUND net buys this past week, reversing last week, which reversed the week before’s flows.

CPMC (906 HK) Responds To Champion’s Offer

By David Blennerhassett

  • On the 30th July 2024, packaging play CPMC Holdings (906 HK) dispatched the Composite Document for the HK$6.87/share, in cash, Offer from SASAC/NCSSF-backed Champion.
  • The Response Document, including the IFA opinion (with a fair & reasonable conclusion) has now been dispatched. 
  • However, the focus remains on ORG Technology Co., Ltd. A (002701 CH)‘s superior HK$7.21/share Offer, which is currently negotiating the necessary regulatory approvals. 

A/H Premium Tracker (To 9 Aug 2024): Global Market Vol. SB Bought. NB Sold. Premia Down.

By Travis Lundy

  • Delayed this week because of the long (Japanese holiday, which I took for myself) weekend, as were the SOUTHBOUND and NORTHBOUND monitors. 
  • SOUTHBOUND inflow strong. Tencent strong inflows. Net buying every day for two weeks. NORTHBOUND outflows large. Record foreign investor outflows from China’s capital markets this year.
  • As expected (with AH 20d Premia returns at multi-year highs last week), AH Premia fell slightly, with narrow premia falling more than wide premia. I’d expect more H-vs-A gains.

WeRide (WRD US) IPO: The Bear Case

By Arun George

  • WeRide (WRD US), a provider of autonomous driving products and services, seeks to raise up to US$119 million through a Nasdaq IPO and US$321 million through a concurrent private placement.
  • In WeRide (WRD US) IPO: The Bull Case, we highlighted the key elements of the bull case. In this note, we outline the bear case.
  • The bear case rests on a volatile revenue profile, high customer concentration risk, widening losses that raise doubts on the path to profitability, elongated cash collection cycles and cash burn.

Alibaba (BABA US): 1Q25 Preview, Stable Growth and Margin, But Overly Impacted

By Ming Lu

  • We believe revenue will increase by 8% YoY in 1Q25, as most business lines have been growing.
  • We believe the operating margin will be stable, as cost cut plans came to an end.
  • We set an upside of 94% for March 2025, as we believe the stock is overly impacted.

China Consumption Weekly (12 Aug 2024): Geely, Li Auto, JD.com, Alibaba, Tencent, DDL

By Ming Lu

  • The retail deliveries of NEV (new energy vehicle) increased by 37% YoY in July.
  • One of Alibaba’s supermarket chains, Freshippo, will sell its OEM goods, on Lazada.
  • Tencent will formally start the game, Arena Breakout: Infinite, in August.

Mainland Connect NORTHBOUND Flows (To 9 Aug 2024): Back to Net Selling of Renewables and Consumer

By Travis Lundy

  • The Quiddity Mainland Connect NORTHBOUND Monitor. Like the A/H Premium Monitor and HK Connect SOUTHBOUND Monitor. Lots of Flows/Position Tables and Charts with which to play.
  • Last week saw NORTHBOUND net SELL RMB 14.8bn of A-shares. It was a big net sell week in relatively low gross NORTHBOUND volume.
  • HK large caps outperformed Mainland large caps generally. Tech (HSTECH vs Star50 and ChiNext) saw even better HK outperformance.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: China Traditional Chinese Medicine, Swire Properties, CanSino Biologics , Plover Bay Technologies, BeiGene , Pacific Basin Shipping, China Resources Beverage, Zylox-Tonbridge Medical Technology, Shui On Land and more

By | China, Daily Briefs

In today’s briefing:

  • Merger Arb Mondays (12 Aug) – China TCM, Canvest, GA Pack, Fuji Soft, Fancl, Descente, Takiron
  • Swire Properties (1972 HK): Buyback to Offset Passive Selling
  • China Healthcare Weekly (Aug.11) – 2024 NRDL Negotiation, China Biotech Outlook, Bottom Fish CanSino
  • Shortlist Of High Conviction Ideas: Income, Value, and Margin of Safety – August 2024
  • BeiGene (6160.HK/BGNE.US) 24Q2 – It Is Time to Open a New Chapter in China’s Pharmaceutical Industry
  • Pacific Basin (2343 HK): Looking for a 2H24 Upturn
  • ECM Weekly (12th Aug 2024) – Ola Electric, Brainbees, WeRide, Akum, CR Beverages, Eternal Beauty
  • Zylox-Tonbridge Medical Technology (2190.HK) – A Good Alpha-Generating Opportunity for Investors
  • Morning Views Asia: Adani Green Energy, New World Development, Rakuten, Shui On Land
  • Morning Views Asia: Adani Green Energy, New World Development, Rakuten, Shui On Land



Swire Properties (1972 HK): Buyback to Offset Passive Selling

By Brian Freitas

  • Swire Properties (1972 HK) was trending lower on expectations of deletion from a global index in August. Short interest has jumped a lot over the last few months.
  • The announcement of the buyback last week took the stock higher. The increased real float from the index deletion will be offset by the buyback.
  • Swire Pacific (A) (19 HK)‘s ownership of Swire Properties (1972 HK) will increase from 82% to 83.5% following the buyback and cancellation of the shares. Privatisation at some point?

China Healthcare Weekly (Aug.11) – 2024 NRDL Negotiation, China Biotech Outlook, Bottom Fish CanSino

By Xinyao (Criss) Wang

  • We summarized the varieties that would miss 2024 NRDL negotiation and have to wait until 2026 to enter medical insurance coverage. This however means competing products would have more advantages.
  • As the NRDL negotiation becomes more transparent/reasonable, there will be a balance point among companies’ profits, patient affordability and medical insurance budget. So, there’s no need to be overly pessimistic.
  • The approval process of CanSino’s PCV13i could be faster than expected. 2024 is the best time to bottom-fish this stock. Reasonable market value is at least RMB5 billion.

Shortlist Of High Conviction Ideas: Income, Value, and Margin of Safety – August 2024

By Sameer Taneja


BeiGene (6160.HK/BGNE.US) 24Q2 – It Is Time to Open a New Chapter in China’s Pharmaceutical Industry

By Xinyao (Criss) Wang

  • BeiGene’s 24Q2 results far exceeded expectations. Sales of BRUKINSA may exceed that of Calquence for the first time next year. Breakeven in 2024 becomes possible if effective cost control continues.
  • BeiGene’s 2024 revenue could exceed Hengrui, marking the official transition of China’s innovative pharmaceutical industry from the old generation to the new one. Reasonable market value for BeiGene is US$19-27.5bn.
  • Current valuation cannot reflect strong fundamentals.As BeiGene has established a convincing profit model, the market turmoil actually provides investors with a good opportunity to buy the stock at low price.

Pacific Basin (2343 HK): Looking for a 2H24 Upturn

By Osbert Tang, CFA

  • Pacific Basin Shipping (2343 HK) may realise at least US$60m of revenue, or around 10% higher total TCE, in 2H24, based on its solid forward vessel coverage.  
  • Sustained re-routing of vessels due to Middle East tension and higher demand from China due to fixed asset spending are supportive of rates. FFA is now 3-4% higher than spot.
  • The stock is inexpensive at 9.7x PER and 0.8x P/B, and its 7.6% dividend yield is attractive. A solid balance sheet also means an upside on the payout ratio. 

ECM Weekly (12th Aug 2024) – Ola Electric, Brainbees, WeRide, Akum, CR Beverages, Eternal Beauty

By Sumeet Singh

  • Aequitas Research’s weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
  • On the IPO front, the prior week witnessed a number of listings with divergent results.
  • Given the market volatility, there was only one large placements in the prior week.

Zylox-Tonbridge Medical Technology (2190.HK) – A Good Alpha-Generating Opportunity for Investors

By Xinyao (Criss) Wang

  • Zylox is a beneficiary of VBP and it has turned losses into profits. 2024 full-year revenue could be up 40-50% YoY. Net profit could be close to RMB100 million.
  • Whether in terms of the number of products on the market or the efficiency of R&D, Zylox’s performance is superior to peers.Its valuation is expected to be higher than peers.
  • We’re in a bear market, together with weak liquidity, Zylox’s valuation doesn’t fully reflect its strong fundamentals. So, while this is a good company, investors may need to be patient.

Morning Views Asia: Adani Green Energy, New World Development, Rakuten, Shui On Land

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Morning Views Asia: Adani Green Energy, New World Development, Rakuten, Shui On Land

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Meituan, Greatview Aseptic Packaging, China Education Group and more

By | China, Daily Briefs

In today’s briefing:

  • O2O Playing a More Prominent Role in China Street Drinks
  • Weekly Deals Digest (11 Aug) – GA Pack, Trend Micro, Descente, Fancl, Fuji Soft, C.I. TAKIRON
  • Technically Speaking, Breakouts and Breakdowns: HONG KONG (AUGUST 9)


O2O Playing a More Prominent Role in China Street Drinks

By Andy Fu

  • On August 7th, Meituan’s on-demand order volume reached a historical high of 98mn on surging orders from street drinks. Meituan has connected to the backend systems of street drink vendors;
  • Delivery order is a double-edged sword. It boosts volume at the expense of margin. Further, the ownership of the volume is questionable;
  • With Pin-hao-fan, Meituan already atomized the small restaurants. Now Meituan is playing the same trick with street drinks. The result will be more dramatic to the benefit of Meituan.

Weekly Deals Digest (11 Aug) – GA Pack, Trend Micro, Descente, Fancl, Fuji Soft, C.I. TAKIRON

By Arun George


Technically Speaking, Breakouts and Breakdowns: HONG KONG (AUGUST 9)

By David Mudd


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Swire Pacific (A), Yum China Holdings , Hang Seng Index, Semiconductor Manufacturing International Corp (SMIC), China Jinmao Holdings and more

By | China, Daily Briefs

In today’s briefing:

  • Thoughts On Swire Properties (1972 HK)’s Buyback
  • Yum China (9987 HK): The Best Long-Term China Catering Play
  • EQD | The HSI Rebound Can Reach Higher Prices in August
  • SMIC (981.HK): Revenue and GM Continued to Trend Up in 3Q24
  • Morning Views Asia: China Jinmao Holdings


Thoughts On Swire Properties (1972 HK)’s Buyback

By David Blennerhassett


Yum China (9987 HK): The Best Long-Term China Catering Play

By Eric Chen

  • We believe Yum China remains the best long-term China catering play. 2Q24 results highlight the resiliency and agility of its business model and management to navigate tough environment.
  • While cost optimization drove bottom-line beat, we share management’s view that it is not one-off exercise but will strengthen the company’s operation efficiency moat and market leadership.
  • Macro concerns are well known and fully priced in in our view. Otherwise investors won’t have the opportunity to own the name for low double-digit P/E.

EQD | The HSI Rebound Can Reach Higher Prices in August

By Nico Rosti

  • In a previous insight we forecasted a rally for the Hang Seng Index in August. The picture has not changed, a positive close above 17344.60 is still possible.
  • Looking at our MRM SHORT WEEKLY model for the HSI we can see that it has not yet reached overbought levels, so it could rise further in the next weeks.
  • Conversely a SHORT trade will be possible from the levels we will indicate below.

SMIC (981.HK): Revenue and GM Continued to Trend Up in 3Q24

By Patrick Liao

  • Expected sequential revenue growth of 13% to 15%, gross margin expected between 18% and 20%.
  • The company has not increased capacity utilization through price cuts but supports customers in facing competition to maintain market share.
  • Inventory replenishment behavior will end in the third quarter, and fourth-quarter orders will more accurately reflect actual demand rather than the impact of restocking.

Morning Views Asia: China Jinmao Holdings

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: WeRide, China Vanke and more

By | China, Daily Briefs

In today’s briefing:

  • WeRide (WRD US) IPO: The Bull Case
  • Morning Views Asia: China Vanke , SK Hynix, Softbank Group, Tata Motors ADR, UPL Ltd, Wynn Macau Ltd


WeRide (WRD US) IPO: The Bull Case

By Arun George

  • WeRide (WRD US), a provider of autonomous driving products and services, seeks to raise between US$200 to US$300 million through a Nasdaq IPO.    
  • WeRide is the most commercially successful L4 autonomous driving company globally, measured by commercialization revenue in 2021, 2022 and 2023.
  • The bull case rests on a large TAM, strong product capabilities, near-term mass commercialization, articulation of a path to profitability, improving earnings quality and presence of blue-chip investors. 

Morning Views Asia: China Vanke , SK Hynix, Softbank Group, Tata Motors ADR, UPL Ltd, Wynn Macau Ltd

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Alibaba Group Holding , MGM China Holdings, Topsports International Holdings, China Resources Sanjiu Medical & Pharma, Yum China Holdings , Black Sesame Technologies, Kuaishou Technology, Cathay Pacific Airways, Hang Lung Properties, Li Auto and more

By | China, Daily Briefs

In today’s briefing:

  • Alibaba (9988 HK/BABA) Dual Primary Listing: Are We There Yet?
  • BUY/SELL/HOLD: Hong Kong Stock Updates (August 6)
  • China: Passive Selling Expected Later This Month
  • CR Sanjiu (000999.CH) To Acquire Tasly Pharma (600535.CH) – SOEs Have High Enthusiasm for TCM Assets
  • Yum China (9987 HK): 2Q 2024 – Market Expansion Can’t Mask Macro Woes
  • Black Sesame IPO Trading – Lackluster Demand, Combined with Bad Timing
  • KS/Kuaishou (1024 HK): 2Q24 Preview, 2-Digit Growth, 5th Profitable Quarter, and Significant Upside
  • Cathay Pacific (293 HK, BUY, TP:9.90HKD): Decent Results, Stay the Course
  • Hang Lung Properties 101 HK: Dragged by China Slowing Luxury Retail, but Stock Too Cheap to Ignore
  • [Blue Lotus Transportation Sector Update]: Consolidation by BYD, LI and Huawei Continue


Alibaba (9988 HK/BABA) Dual Primary Listing: Are We There Yet?

By Brian Freitas

  • In its last update, Alibaba Group announced that the company was preparing for its primary listing in Hong Kong and the process was expected to complete by the end August.
  • The Board meets on 14 August to approve results for the three months ending June. Could there be an announcement on the dual primary listing too?
  • Mainland Chinese own between 3.5%-15.5% of companies that converted from Secondary to Dual-Primary in the last few years. Similar buying in Alibaba could take the stock higher from here. 

BUY/SELL/HOLD: Hong Kong Stock Updates (August 6)

By David Mudd


China: Passive Selling Expected Later This Month

By Brian Freitas

  • The China equity markets have continued to trade lower with the CSI 300 Index outperforming other mainland indices as the National Team continues to pump money into ETFs tracking the index.
  • We currently estimate selling of around US$1.39bn across 74 stocks listed on the mainland and in Hong Kong. There could be fewer deletions depending on the review date chosen.
  • The potential deletes have dropped a lot since the start of the calendar year with big underperformance versus the HSCEI Index, CSI 300 Index and CSI Smallcap 500 Index.

CR Sanjiu (000999.CH) To Acquire Tasly Pharma (600535.CH) – SOEs Have High Enthusiasm for TCM Assets

By Xinyao (Criss) Wang

  • China Resources Sanjiu plans to acquire 28% stake in Tasly for RMB6.21 billion at RMB14.85/share. The acquisition of Tasly is in line with the strategic direction of 14th Five-Year Plan.
  • China Resources is positioned as a leading enterprise in modern industrial chain of TCM by the SASAC.Due to policy support, TCM assets are more likely to be favored by SOEs.
  • The deal is positive for Tasly, whose valuation has room to rise further, but the market seems “skeptical” about China Resources Sanjiu’s decision, leading to a lackluster share price reaction. 

Yum China (9987 HK): 2Q 2024 – Market Expansion Can’t Mask Macro Woes

By Devi Subhakesan

  • Yum China Holdings (9987 HK) reported a marginal 1% year-on-year increase in 2Q2024 revenue, driven by new store additions despite a decline in same-store sales.
  • Despite a challenging business environment, it achieved 8% year-on-year profit growth in Q2 and stabilised margins through sharp cost management and operational efficiency initiatives.
  • Without a clear visibility in improvement in consumer sentiment and spending, expect the tough operating environment to limit Yum China’s revenue and profit growth potential.

Black Sesame IPO Trading – Lackluster Demand, Combined with Bad Timing

By Clarence Chu

  • Black Sesame Technologies (BLACKSES HK) raised around US$133m in its Hong Kong IPO, after pricing its IPO at the low-end.
  • Black Sesame International Holdings (BSIH) is an automotive-grade computing SoC and SoC-based intelligent vehicle solution provider.
  • We have covered various aspects of the deal in our previous note. In this note, we will talk about the demand and trading dynamics.

KS/Kuaishou (1024 HK): 2Q24 Preview, 2-Digit Growth, 5th Profitable Quarter, and Significant Upside

By Ming Lu

  • We believe revenue will grow by 11% YoY and the company will make money for the fifth consecutive quarter in 2Q24.
  • We believe both adverting and e-commerce revenue will grow strongly in 2Q24.
  • We set an upside of 140% and a price target at HK$104 for the end of 2025. Buy.

Cathay Pacific (293 HK, BUY, TP:9.90HKD): Decent Results, Stay the Course

By Mohshin Aziz

  • 1HFY24 net profit declined -15% YoY to HK$3.4 billion, in-line with consensus 
  • Interim dividend of HK$0.20/share, at 38% payout ratio. Typically, Cathay pays 50% payout ratio, and we can expect final dividend to be much larger
  • Maintain BUY with target price of HK$9.90 (+26% UPSIDE) implies 10x FY2024 PE, parity multiple against its arch-rival Singapore Airlines (SIA SP). 

Hang Lung Properties 101 HK: Dragged by China Slowing Luxury Retail, but Stock Too Cheap to Ignore

By Jacob Cheng

  • HLP malls, which focus on China luxury retail consumption, is facing headwind from slowing China economy and weaker consumption
  • The retail sales in its malls slowed down and recorded -13% yoy growth for 1H 2024.  Dividend cut was a negative surprise
  • However, market is forward looking and stock valuation is too cheap to ignore, we recommend long-term investors can look at this name

[Blue Lotus Transportation Sector Update]: Consolidation by BYD, LI and Huawei Continue

By Eric Wen

  • Market underestimates the size of China’s stimulus packages, which consist of Rmb150bn of EV trade-in’s by year end and Rmb3tn worth of industrial equipment upgrades over 5 years;
  • Consolidation by BYD, LI and Huawei in marketing share shall continue, profitably. Our TOP PICK is BYD.
  • Consolidation by BYD, LI and Huawei in marketing share shall continue, profitably. Our TOP PICK is BYD.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Greatview Aseptic Packaging, WeRide Corp, Horizon Robotics, New World Development, Eternal Beauty Holdings Limited, Hutchmed China Ltd, China Resources Beverage, Road King Infrastructure, Medco Energi and more

By | China, Daily Briefs

In today’s briefing:

  • GA Pack (468 HK): Stalemate Broken as Management Considers a Possible Counteroffer
  • GAPack (468 HK)’s Co-Founders (Almost) Walk The Walk
  • WeRide Pre-IPO – Peer Comparison – Boasting Partnerships, but Peers Aren’t Too Far Behind
  • Horizon Robotics IPO: High Valuation Is At Risk As NEV Production Forecasts Have Weakened
  • NWD 17 HK Update: De-Leveraging in Process, the Biggest Beneficiary of Fed Rate Cut Cycle
  • Eternal Beauty Pre-IPO Tearsheet
  • Hutchmed China Ltd (13.HK/​​HCM.US) 24H1 – Fruquintinib’s US Sales Beat; Break-Even Is Within Reach
  • China Resources Beverage Pre-IPO – Peer Comparison – Middling
  • Road King – ESG Report – Lucror Analytics
  • Morning Views Asia: Greentown China, Medco Energi, Vedanta Resources


GA Pack (468 HK): Stalemate Broken as Management Considers a Possible Counteroffer

By Arun George

  • Greatview Aseptic Packaging (468 HK) disclosed that Mr Bi Hua Jeff (CEO) and Mr Hong Gang (co-founder) are contemplating a possible voluntary conditional offer. The terms and conditions were not disclosed.
  • Due to the recent AGM protest votes, management needed to provide a credible alternative to shareholders to ensure that Shandong Xinjufeng Technology Packaging (301296 CH)’s offer failed.   
  • Shandong Xinjufeng’s likely game plan is to wait for a binding counteroffer, focus on satisfying the preconditions, and requisition an EGM again to get Board representation.

GAPack (468 HK)’s Co-Founders (Almost) Walk The Walk

By David Blennerhassett

  • To say Greatview Aseptic Packaging (468 HK)‘s management and Shandong Xinjufeng (301296 CH) (XJF) don’t get along is an understatement. GAPack has labelled XJF’s pre-conditional Offer hostile and unwelcome.
  • Last night (6th August), co-founders Jeff Bi and Gang Hong tabled a non-binding Offer. No price was mentioned. Collectively they hold 14.72% of shares out compared to XJF’s 26.8%.
  • A firm Offer (and price) would have been welcome, and this probably reflects on-going funding negotiations. But the announcement will give minorities pause if/when tendering into XJF’s Offer.

WeRide Pre-IPO – Peer Comparison – Boasting Partnerships, but Peers Aren’t Too Far Behind

By Clarence Chu

  • WeRide Corp (WER CH) is looking to raise around US$300m in its upcoming US IPO.
  • WeRide provides autonomous driving products and services from L2 to L4 of driving automation.
  • We had looked at the firm’s past performance in an earlier note. In this note, we will undertake a peer comparison.

Horizon Robotics IPO: High Valuation Is At Risk As NEV Production Forecasts Have Weakened

By Andrei Zakharov

  • Horizon Robotics, a leading provider of ADAS and AD solutions for passenger vehicles, plans to raise up to $500M in Hong Kong IPO.
  • I expect Horizon Robotics will price its IPO below last round valuation of ~$8.7B as revenue growth will slow below 50% y/y in 2024, down from 71% y/y in 2023.
  • The company’s key competitors, including Mobileye and Microchip Technology, revised their revenue guidance downwards for the second half of 2024.

NWD 17 HK Update: De-Leveraging in Process, the Biggest Beneficiary of Fed Rate Cut Cycle

By Jacob Cheng

  • In this update, we analyzed recent NWD’s corporate actions, which show their de-leveraging plan is on track
  • NWD, having the highest gearing among HK RE names, will become the biggest beneficiary if Fed starts a new rate cut cycle
  • Valuation is compelling.  There is ample upside assuming a bear case scenario.  It is a BUY

Eternal Beauty Pre-IPO Tearsheet

By Akshat Shah

  • Eternal Beauty Holdings Limited (EBHL12 HK) is looking to raise about US$200m in its upcoming Hong Kong IPO. The deal will be run by BNP Paribas, Citic, CMBI and DBS.
  • Eternal Beauty is the largest brand management company of perfumes in the combined markets of Mainland China, Hong Kong and Macau, in terms of retail sales in 2023.
  • The company has a diverse portfolio of iconic brands of not only perfumes, but also color cosmetics, skincare products, personal care products, eyewear and home fragrances under management.

Hutchmed China Ltd (13.HK/​​HCM.US) 24H1 – Fruquintinib’s US Sales Beat; Break-Even Is Within Reach

By Xinyao (Criss) Wang

  • Fruquintinib US sales continue to be the main performance driver. License-out expectations for surufatinib is low.Highlight for savolitinib is the combination with osimertinib for NSCLC, which would bring high growth.
  • Future playbook of HUTCHMED is “continued sharp reduction of expenses + milestones from Takeda based on fruquintinib overseas sales = rapid narrowng of losses”.2024 overseas market sales may exceed US$300m.
  • There is not much problem with HUTCHMED completing its performance guidance for the year 2024. Reasonable market value range for HUTCHMED is US$1.75-3.75 billion. Breakeven is expected in 2025.

China Resources Beverage Pre-IPO – Peer Comparison – Middling

By Sumeet Singh

  • China Resources Beverage is looking to raise US$1bn in its upcoming Hong Kong IPO.
  • China Resources Beverage manufactures and sells packaged drinking water and RTD soft beverages in China.
  • In our earlier note, we talked about the company’s past performance. In this note, we will undertake a peer comparison.

Road King – ESG Report – Lucror Analytics

By Leonard Law, CFA

Lucror Analytics’ ESG Scores are based on a 3-tiered scale and are adjusted for Controversies (if applicable).
We assess Road King’s ESG as “Adequate”, in line with the Environmental, Social and Governance scores. Controversies are “Immaterial” and Disclosure is “Adequate”.


Morning Views Asia: Greentown China, Medco Energi, Vedanta Resources

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars